Medical Weight Loss for Butte, Montana Residents
Butte, Montana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Butte through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Butte Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Butte, Montana residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Butte is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Butte address.
Patients across Butte and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Montana. We care for patients throughout Uptown Butte and the greater Silver Bow County area. Every prescription for Butte is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Telehealth removes the distance between Butte and specialized care: your consultation happens wherever you are in Montana. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Butte patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Butte
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Butte
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Butte address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Butte
Does New Hope Weight Loss treat patients in Butte?
Yes. Although the clinic is in Costa Mesa, California, we treat Butte, Montana residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Butte?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Butte address in cold-pack packaging.
What do Butte patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Butte do you serve?
We serve patients from across Butte by telehealth, including Uptown Butte and the greater Silver Bow County area.
What makes this different from a local Butte medspa or clinic?
A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Butte patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Butte, Montana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.